Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Delegates Go To China; Business Ethics Code In The Works

This article was originally published in PharmAsia News

Executive Summary

AdvaMed and Chinese device makers agreed to harmonize China's standards for ethical business practices with AdvaMed's code of ethics and other international policies in a memorandum of understanding signed earlier this month

You may also be interested in...



Imaging Industry Expands Emerging Market Focus

A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector's top lobbyist

Imaging Industry Expands Emerging Market Focus

A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector's top lobbyist

China's Device Classification System And Country Of Origin Requirements Weigh On Foreign Companies

BEIJING - Foreign medical device manufacturers frustrated with China's medical device classification system and country of origin requirements are starting to take an "if you can't beat them, joint them" approach and are shifting more manufacturing to China, according to panelists at a recent regulatory conference in Beijing

Related Content

UsernamePublicRestriction

Register

SC075965

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel